110 related articles for article (PubMed ID: 24740354)
1. Recurrent salivary pleomorphic adenoma shows increased immunohistologic expression of bcl-2 oncoprotein.
Obtulovicova K; Starek I; Salzman R; Kalis A; Ehrmann J; Sicak M; Dvorackova J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Sep; 159(3):460-5. PubMed ID: 24740354
[TBL] [Abstract][Full Text] [Related]
2. Pleomorphic adenoma of oral minor salivary glands: An investigation of its neoplastic potential based on apoptosis, mucosecretory activity and cellular proliferation.
Ferreira JC; Morais MO; Elias MR; Batista AC; Leles CR; Mendonça EF
Arch Oral Biol; 2014 Jun; 59(6):578-85. PubMed ID: 24681706
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical pattern of Bcl-2- and PTHrP-positive cells in primary, in recurrent and in carcinoma in pleomorphic adenomas.
Sunardhi-Widyaputra S; Van Damme B
Pathol Res Pract; 1995 Dec; 191(12):1186-91. PubMed ID: 8927564
[TBL] [Abstract][Full Text] [Related]
4. Increased mucin 1 expression in recurrence and malignant transformation of salivary gland pleomorphic adenoma.
Soares AB; Demasi AP; Altemani A; de Araújo VC
Histopathology; 2011 Feb; 58(3):377-82. PubMed ID: 21323961
[TBL] [Abstract][Full Text] [Related]
5. Expression of cyclooxygenase-2, Bcl-2 and Ki-67 in pleomorphic adenoma with special reference to tumor proliferation and apoptosis.
Aoki T; Tsukinoki K; Karakida K; Ota Y; Otsuru M; Kaneko A
Oral Oncol; 2004 Oct; 40(9):954-9. PubMed ID: 15380175
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of the Rb pathway in recurrent pleomorphic adenoma of the salivary glands.
de Souza AA; Altemani A; Passador-Santos F; Turssi CP; de Araujo NS; de Araújo VC; Soares AB
Virchows Arch; 2015 Sep; 467(3):295-301. PubMed ID: 26155914
[TBL] [Abstract][Full Text] [Related]
7. Carcinoma ex pleomorphic adenoma of the salivary gland: an immunohistochemical study.
Matsubayashi S; Yoshihara T
Eur Arch Otorhinolaryngol; 2007 Jul; 264(7):789-95. PubMed ID: 17310348
[TBL] [Abstract][Full Text] [Related]
8. PLAG1 expression is maintained in recurrent pleomorphic adenoma.
de Brito BS; Gaspar NG; Egal ES; Sanchez-Romero C; Martins AS; Tincani ÁJ; de Oliveira Gondak R; de Almeida OP; Kowalski LP; Altemani A; Mariano FV
Virchows Arch; 2016 Oct; 469(4):477-81. PubMed ID: 27381214
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of metallothionein in pleomorphic adenoma of minor salivary glands: a role in the control of apoptosis?
Miranda Viana Ade C; Ribeiro DC; Florêncio TN; Santos VT; Sousa AA; Aguiar MC
Acta Histochem; 2013 Jul; 115(6):564-8. PubMed ID: 23332881
[TBL] [Abstract][Full Text] [Related]
10. Proliferative potential in benign mixed salivary gland tumors and its value in primary and recurrent neoplasms.
Kazanceva A; Groma V; Smane L; Kornevs E; Teibe U
Stomatologija; 2011; 13(2):35-41. PubMed ID: 21822043
[TBL] [Abstract][Full Text] [Related]
11. An immunohistochemical study of XIAP expression in pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Hoch BL; Wu M; Lewis M; Gan L; Burstein DE
J Oral Pathol Med; 2008 Nov; 37(10):634-8. PubMed ID: 18673415
[TBL] [Abstract][Full Text] [Related]
12. The increased PDGF-A, PDGF-B and FGF-2 expression in recurrence of salivary gland pleomorphic adenoma.
Soares AB; Demasi AP; Tincani AJ; Martins AS; Altemani A; de Araújo VC
J Clin Pathol; 2012 Mar; 65(3):272-7. PubMed ID: 22174424
[TBL] [Abstract][Full Text] [Related]
13. Angiogenic and lymphangiogenic microvessel density in recurrent pleomorphic adenoma.
Soares AB; de Araújo VC; Juliano PB; Altemani A
J Oral Pathol Med; 2009 Sep; 38(8):623-9. PubMed ID: 19563505
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of nucleolar organizer regions in recurrent pleomorphic adenomas of salivary glands.
Criscuolo M; Migaldi M; Collina G; Cesinaro AM; Galetti R; Lo Bianco F; Trentini GP
Pathologica; 1994 Dec; 86(6):606-11. PubMed ID: 7617389
[TBL] [Abstract][Full Text] [Related]
15. Carcinoma ex pleomorphic adenoma of minor salivary glands with major epithelial-myoepithelial component: clinicopathologic and immunohistochemical study of 3 cases.
Sedassari BT; Dos Santos HT; Mariano FV; da Silva Lascane NA; Altemani A; Sousa S
Ann Diagn Pathol; 2015 Jun; 19(3):164-8. PubMed ID: 25890488
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of P(53) and bcl-2 in benign and malignant salivary glands tumors.
Al-Rawi NH; Omer H; Al Kawas S
J Oral Pathol Med; 2010 Jan; 39(1):48-55. PubMed ID: 19761475
[TBL] [Abstract][Full Text] [Related]
17. Expression of estrogen receptor, progesterone receptor, and insulin-like growth factor receptor-1 and of MIB-1 in patients with recurrent pleomorphic adenoma of the parotid gland.
Glas AS; Hollema H; Nap RE; Plukker JT
Cancer; 2002 Apr; 94(8):2211-6. PubMed ID: 12001119
[TBL] [Abstract][Full Text] [Related]
18. The role of aryl hydrocarbon receptor (AhR) in the pathology of pleomorphic adenoma in parotid gland.
Drozdzik A; Kowalczyk R; Lipski M; Łapczuk J; Urasinska E; Kurzawski M
Arch Oral Biol; 2016 Jan; 61():53-9. PubMed ID: 26513682
[TBL] [Abstract][Full Text] [Related]
19. Pleomorphic adenoma-like tumour of the breast.
Rakha EA; Aleskandarany MA; Samaka RM; Hodi Z; Lee AH; Ellis IO
Histopathology; 2016 Feb; 68(3):405-10. PubMed ID: 26096183
[TBL] [Abstract][Full Text] [Related]
20. Pleomorphic adenoma and carcinoma ex pleomorphic adenoma: immunohistochemical demonstration of the association between tenascin expression and malignancy.
Félix A; Rosa JC; Fonseca I; Cidadão A; Soares J
Histopathology; 2004 Aug; 45(2):187-92. PubMed ID: 15279638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
